Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 Dicembre;54(6) > The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 Dicembre;54(6):574-81

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


eTOC

 

REVIEWS  MONOCLONAL ANTIBODIES FOR DIAGNOSIS AND THERAP Y DECISION MAKING IN INFLAMMATION/INFECTION


The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 Dicembre;54(6):574-81

lingua: Inglese

An overview of the diagnostic and therapeutic use of monoclonal antibodies in medicine

Goldsmith S. J. 1, Signore A. 2

1 New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, NY, USA;
2 Nuclear Meidicine Unit, Faculty of Medicine and Psychology, La Sapienza University, Rome, Italy


PDF  


Monoclonal antibodies, which include murine, chimeric, humanised and fully human antibodies, bind to their target receptors with high affinity and specificity. In the last two decades several different monoclonal antibodies have been approved by the Food and Drug Administration for therapeutic purposes, and some of these and others have also been radiolabelled for diagnostic and therapeutic purposes. This field is in continuous evolution and this overview highlights the role of radiolabelled antibodies in research and clinical setting.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

sjg2002@med.cornell.edu